For the Inventor, By the Inventor

Enter assignee name

Middlesex, United Kingdom

Glaxo Group Limited

USPTO Granted Patents = 1,168

CIPO Patents = 26

EPO Patents = 273

Trademarks = 885

Forward Citations = 16,776

Loading Chart...

Loading Chart...

1,322 inventors (with patents filed for the assignee):

Paul Kenneth Rand (72 out of 92 patents)

Alan Naylor (39 out of 57 patents)

Ian H Coates (39 out of 41 patents)

4. Harry Finch (37 out of 47 patents)

5. Alexander W Oxford (37 out of 58 patents)

6. John W Clitherow (34 out of 40 patents)

7. Michael Birsha Davies (33 out of 37 patents)

8. John Bradshaw (33 out of 40 patents)

9. Keith Biggadike (31 out of 51 patents)

10. Michael B Tyers (31 out of 31 patents)

11. Anthony James Taylor (29 out of 30 patents)

12. Lawrence H Lunts (29 out of 29 patents)

13. Peter C North (26 out of 27 patents)

14. Duncan B Judd (26 out of 26 patents)

15. David E Bays (25 out of 29 patents)

Core Competencies:

Inhalation Devices

Muscarinic Receptor Antagonists

Recombinant Proteins

Antigen Binding Proteins

Pharmaceutical Formulations

Protease Resistant Polypeptides

Positive Allosteric Modulators

Nucleic Acids

Fluid Dispensers

Benzofuran Compounds

Chemical Processes

Humanized Antibodies

1,168 patents: Sort by Forward Citations

1. D1104149 - Label set for an inhalation device (2025-12-02),

2. 12396986 - Combinations of a muscarinic receptor antagonist and a β-2 adrenoreceptor agonist (2025-08-26),

3. 11667887 - Method of producing a recombinant protein (2023-06-06),

4. 11419945 - Antigen binding proteins (2022-08-23),

5. D938521 - Label set for an inhalation device (2021-12-14),

6. 11116721 - Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol (2021-09-14),

7. 11090294 - Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist (2021-08-17),

8. 10946025 - Compounds (2021-03-16),

9. 10808040 - Modified proteins and peptides (2020-10-20),

10. 10808029 - Antigen binding proteins to oncostatin M (OSM) (2020-10-20),

11. 10703814 - Method of treatment with humanized anti-IL-18 antibodies (2020-07-07),

12. 10633673 - Production methods (2020-04-28),

13. 10624898 - Compounds (2020-04-21),

14. 10548827 - Composition (2020-02-04),

15. 10466252 - Methods for selecting protease resistant polypeptides (2019-11-05),

Glaxo Group Limited is a British multinational pharmaceutical company. It specializes in researching, developing, manufacturing, and marketing pharmaceutical medicines, vaccines, and consumer healthcare products. With a mission to help people do more, feel better, and live longer, GSK focuses on areas such as respiratory, vaccines, and HIV/AIDS. The company operates globally, aiming to improve the health and well-being of individuals around the world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

1,168 Patents

#1 in Middlesex

#10 in United Kingdom

#846 in the World

Middlesex, United Kingdom

Glaxo Group Limited

Forward Citations = 16,776

1,322 inventors:

Paul Kenneth Rand (72 out of 92 patents)

Alan Naylor (39 out of 57 patents)

Ian H Coates (39 out of 41 patents)

4. Harry Finch (37 out of 47 patents)

5. Alexander W Oxford (37 out of 58 patents)

Please report any incorrect information to support@idiyas.com

Loading…